FF
TBIO

FourThought Financial’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

FourThought Financial’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-126
Closed -$12K – 1578
2022
Q1 		$12K Buy
+126
New +$19.1K ﹤0.01% 1016

Other funds holding TBIO

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FourThought Financial's TBIO Position: Q2 2022 in Review

FourThought Financial sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q2 2022, closing a stake of 126 shares — an estimated $12K sold.

FourThought Financial first reported a position in TBIO in Q1 2022 and held it in 1 quarter. The position peaked at $12K in Q1 2022. 37 funds tracked by Wall St. Rank hold TBIO as of Q2 2022.

  • FourThought Financial reported no remaining Telesis Bio, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • FourThought Financial sold 126 Telesis Bio, Inc. Common Stock shares in Q2 2022, an estimated $12K.
  • FourThought Financial first reported a position in Telesis Bio, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • FourThought Financial's Telesis Bio, Inc. Common Stock position peaked at $12K in Q1 2022.
  • 37 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q2 2022.

Based on FourThought Financial's 13F filing for Q2 2022, filed 12 Aug 2022.